Ovid Therapeutics Inc
NASDAQ:OVID
Ovid Therapeutics Inc
NASDAQ:OVID
Price:
2.79
USD
1.45%
Market Closed
Market Cap:
$363.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
US |
|
SDIC Power Holdings Co Ltd
SSE:600886
|
CN |
|
P
|
PBS Bhd
KLSE:PBSB
|
MY |
|
R
|
Routon Electronic Co Ltd
SSE:600355
|
CN |
|
Central China Securities Co Ltd
SSE:601375
|
CN |
|
Fast Finance 24 Holding AG
XETRA:FF24
|
DE |
|
R
|
Revenue Group Bhd
KLSE:REVENUE
|
MY |
|
Cotta Co Ltd
TSE:3359
|
JP |
|
Takada Corp
TSE:1966
|
JP |
|
S
|
Shanghai Shibei Hi-Tech Co Ltd
SSE:600604
|
CN |
Balance Sheet
Balance Sheet Decomposition
Ovid Therapeutics Inc
Ovid Therapeutics Inc
Balance Sheet Decomposition is not available for
Ovid Therapeutics Inc
Ovid Therapeutics Inc
Balance Sheet
Ovid Therapeutics Inc
Ovid Therapeutics Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
5
|
70
|
52
|
87
|
37
|
42
|
72
|
188
|
45
|
27
|
26
|
13
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
3
|
3
|
1
|
1
|
|
| Cash Equivalents |
5
|
70
|
52
|
87
|
36
|
41
|
70
|
188
|
42
|
24
|
26
|
13
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
5
|
35
|
0
|
0
|
84
|
79
|
27
|
56
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
3
|
2
|
3
|
3
|
2
|
4
|
3
|
5
|
|
| Total Current Assets |
5
|
70
|
52
|
89
|
44
|
80
|
75
|
191
|
131
|
110
|
56
|
74
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
15
|
13
|
12
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
15
|
13
|
12
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
6
|
18
|
21
|
63
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
3
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
5
N/A
|
70
+1 337%
|
53
-25%
|
90
+69%
|
48
-47%
|
81
+70%
|
76
-6%
|
195
+156%
|
155
-20%
|
144
-7%
|
92
-36%
|
151
+64%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
4
|
3
|
5
|
7
|
2
|
4
|
3
|
2
|
|
| Accrued Liabilities |
0
|
2
|
3
|
4
|
5
|
7
|
12
|
8
|
5
|
8
|
7
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
4
|
6
|
9
|
11
|
22
|
15
|
7
|
11
|
11
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
16
|
45
|
13
|
12
|
|
| Total Liabilities |
0
N/A
|
2
+2 200%
|
4
+61%
|
6
+62%
|
9
+47%
|
11
+23%
|
32
+199%
|
15
-54%
|
23
+55%
|
56
+144%
|
24
-57%
|
20
-15%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
14
|
36
|
101
|
153
|
213
|
294
|
171
|
226
|
278
|
304
|
322
|
|
| Additional Paid In Capital |
5
|
82
|
85
|
184
|
192
|
283
|
338
|
351
|
358
|
366
|
372
|
452
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
68
+1 349%
|
49
-28%
|
83
+69%
|
39
-53%
|
70
+80%
|
44
-38%
|
180
+312%
|
132
-26%
|
88
-34%
|
68
-22%
|
131
+92%
|
|
| Total Liabilities & Equity |
5
N/A
|
70
+1 337%
|
53
-25%
|
90
+69%
|
48
-47%
|
81
+70%
|
76
-6%
|
195
+156%
|
155
-20%
|
144
-7%
|
92
-36%
|
151
+64%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
25
|
25
|
55
|
66
|
70
|
71
|
71
|
71
|
130
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
